TI
IPSC icon

Trexquant Investment’s Century Therapeutics IPSC Stock Holding History

Trexquant Investment’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-32,630
Closed -$103K – 1632
2023
Q2 		$103K Sell
32,630
-21,261
-39% -$68.5K ﹤0.01% 1370
2023
Q1 		$187K Buy
53,891
+32,350
+150% +$142K 0.01% 1330
2022
Q4 		$111K Sell
21,541
-3,065
-12% -$28.9K ﹤0.01% 1312
2022
Q3 		$243K Buy
+24,606
New +$259K 0.01% 1114

Other funds holding IPSC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Trexquant Investment's IPSC Position: Q3 2023 in Review

Trexquant Investment sold out of Century Therapeutics (IPSC) in Q3 2023, closing a stake of 32,630 shares — an estimated $103K sold.

Trexquant Investment first reported a position in IPSC in Q3 2022 and held it in 4 quarters. The position peaked at $243K in Q3 2022. 55 funds tracked by Wall St. Rank hold IPSC as of Q3 2023.

  • Trexquant Investment reported no remaining Century Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Trexquant Investment sold 32,630 Century Therapeutics shares in Q3 2023, an estimated $103K.
  • Trexquant Investment first reported a position in Century Therapeutics in Q3 2022 and held it in 4 quarters.
  • Trexquant Investment's Century Therapeutics position peaked at $243K in Q3 2022.
  • 55 funds tracked by Wall St. Rank held Century Therapeutics as of Q3 2023.

Based on Trexquant Investment's 13F filing for Q3 2023, filed 13 Nov 2023.